[(1R)-1-[(5Z)-4-bromo-5-(bromomethylene)-2-oxo-3-furyl]butyl] acetate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氢呋喃
• 英文名称: [(1R)-1-[(5Z)-4-bromo-5-(bromomethylene)-2-oxo-3-furyl]butyl] acetate
• 英文别名: [(1R)-1-[(5Z)-4-bromo-5-(bromomethylidene)-2-oxofuran-3-yl]butyl] acetate
• 化学式: C₁₁H₁₂Br₂O₄
• 分子量: 368.02
• InChiKey: ZHKRZTOJPXQAJI-BESBCXERSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  17
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• Production of furanones
  申请人：Biosignal Australia Pty Limited

  公开号：EP1787988A2

  公开（公告）日：2007-05-23

  The present invention relates to the side chain functionalisation of fimbrolides (halogenated 3-alkyl-5-methylene-2(5H)-furanones) and their synthetic analogues, that yields fimbrolides substituted with a halogen, an oxygen or a nitrogen functionality in the alkyl chain, especially fimbrolide alcohols, carboxylate and sulfinate and sulfonate esters, ethers, aldehydes, ketones, acids, amides, nitro derivatives, hydrophobic, hydrophilic and fluorophilic alkyl derivatives and polymers.

  本发明涉及芬普罗内酯（卤代 3-烷基-5-亚甲基-2(5H)-呋喃酮）及其合成类似物的侧链官能化，从而得到在烷基链中被卤素、氧或氮官能团取代的芬普罗内酯，特别是芬普罗内酯醇、羧酸酯、硫酸酯和磺酸酯、醚、醛、酮、酸、酰胺、硝基衍生物、疏水性、亲水性和亲氟烷基衍生物及聚合物。
• ANTIMICROBIAL COATINGS
  申请人：Biosignal Australia Pty Limited

  公开号：EP1296673B1

  公开（公告）日：2008-07-23
• PATIENT INTERFACE
  申请人：KONINKLIJKE PHILIPS N.V.

  公开号：US20160317771A1

  公开（公告）日：2016-11-03

  Patient interface ( 50 ) optically indicating a user that a member ( 22 ) of the patient interface ( 50 ) needs to be replaced due to wear. In particular, it relates to a member ( 22 ) for patient interface ( 50 ) which comprises at least one functional material ( 32, 34 ) having a predefined functionality and at least one indicator ( 28, 30 ) wherein the concentration of said at least one indicator ( 28, 30 ) in said member ( 22 ) correlates with the predefined functionality of said at least one functional material ( 32, 34 ).
• US7625579B2
  申请人：——

  公开号：US7625579B2

  公开（公告）日：2009-12-01